The availability of targeted therapies has changed the landscape of cancer treatment in the last few years. And two types of cancer particularly affected by these advances are melanoma and non-small cell lung carcinoma or NSCLC. What role does the laboratory play in the diagnosis and treatment of these cancers? How can pathologists and lab professionals work with oncologists to optimize biomarker testing and improve patient outcomes? On this episode of Inside the Lab, your hosts, Ms. Kelly Swails, MT(ASCP), and Dr. Ali Brown, MD, FASCP, are joined by Dr. Sanjay Mukhopadhyay, MD, Director of the Lung Pathology Service at the Cleveland Clinic, Ms. Lynnette Pineault, MBA, SCT(ASCP), Operations Manager for Laboratory and Genetic Services for Health Partners, and Mr. Jim Ondick, ASCP Patient Champion and IT Associate at The University of Kansas Health System, to discuss advancements in biomarker testing to improve NSCLC and melanoma cancer care. Listen in for insight on ensuring equitable patient access to biomarker testing and learn how to register for ASCP’s Immuno-Oncology Microlearning Courses for pathologists and laboratory professionals. Topics Covered  How targeted therapies and immunotherapies have improved treatment for melanoma and lung cancer in the past few years Mr. Ondick’s success story of being treated with immunotherapy for metastatic melanoma and why he had little interaction with laboratory professionals during his diagnosis and treatmentHow pathologists can work with oncologists and surgeons to improve care for patients with cancer The obstacles to providing laboratory services or support for biomarker testing Dr. Mukhopadhyay and Ms. Pineault’s advice on designing workflows to optimize biomarker testing and ensuring equitable access for patients Mr. Ondick’s take on what cancer patients should know about the laboratory team Connect with ASCP ASCP ASCP on Facebook ASCP on Instagram ASCP on Twitter Connect with Dr. Mukhopadhyay Dr. Mukhopadhyay at Cleveland Clinic Dr. Mukhopadhyay on LinkedIn Connect with Ms. Pineault Ms. Pineault on ResearchGate Ms. Pineault on LinkedIn Connect with Mr. Ondick Mr. Ondick on LinkedIn Mr. Ondick’s Story on ASCP Patient Champions Connect with Ms. Swails & Dr. Brown Ms. Swails on Twitter Dr. Brown on Twitter Resources ASCP Patient ChampionsASCP Immuno-Oncology Microlearning Courses Inside the Lab in the ASCP Store Sponsor Bristol Myers Squibb

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related